Aldeyra Therapeutics, Inc. (ALDX)
5.56
+0.03
(+0.54%)
USD |
NASDAQ |
Feb 09, 16:00
5.65
+0.09
(+1.62%)
After-Hours: 04:46
Aldeyra Therapeutics EPS Diluted (Quarterly) : -0.1279 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 1.612 |
| MediciNova, Inc. | -0.0622 |
| Altimmune, Inc. | -0.2126 |
| Actinium Pharmaceuticals, Inc. | -0.1645 |
| Avanos Medical, Inc. | -0.0302 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.688M |
| Total Expenses (Quarterly) | 7.688M |
| Enterprise Value | 274.75M |
| Earnings Yield | -12.98% |
| Normalized Earnings Yield | -12.98 |